Comorbidities relevant to CML TKI choice common

November 27, 2015

Comorbid conditions that could affect the choice of tyrosine kinase inhibitor are common in patients with chronic myeloid leukaemia, finds an analysis of a US claims database.

Previous Article
ClinicAll's innovative software solution provides flexible access to patient health records
ClinicAll's innovative software solution provides flexible access to patient health records

The health system is set to go online. The potential to save costs, improve treatment quality and accelerat...

Next Article
Epilepsy common but variable in mitochondrial disease patients
Epilepsy common but variable in mitochondrial disease patients

Around a quarter of patients with mitochondrial diseases have seizures, but these do not appear to increase...